AELIS FARMA
New brain disease treatments
- B2B
About AELIS FARMA
Develops unique drug candidates, Signaling Specific inhibitors of the CB1 receptor, for treating various brain pathologies, including cannabis use disorders and cognitive deficits.
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Bordeaux, Nouvelle-Aquitaine, France
- Founded
- 2013
- Revenue
- €432KFY2025, publicly reported
- Website
- aelisfarma.com
- linkedin.com/company/aelis-farma
AELIS FARMA at a glance
AELIS FARMA is a B2B company in the Biotechnology Research industry, headquartered in Bordeaux, Nouvelle-Aquitaine, France.
AELIS FARMA was founded in 2013.
AELIS FARMA has 11–50 employees.
AELIS FARMA's revenue is €432K (FY2025, publicly reported).
Selling to companies like AELIS FARMA?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies